Contrasting ASP Isotopes (ASPI) & Its Rivals

ASP Isotopes (NASDAQ:ASPI) is one of 18 public companies in the “Miscellaneous chemical products” industry, but how does it weigh in compared to its peers? We will compare ASP Isotopes to related companies based on the strength of its dividends, valuation, analyst recommendations, earnings, institutional ownership, risk and profitability.

Valuation & Earnings

This table compares ASP Isotopes and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
ASP Isotopes	N/A	-$4.95 million	-2.84
ASP Isotopes Competitors	$1.22 billion	$32.20 million	13.03

ASP Isotopes’ peers have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares ASP Isotopes and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	N/A	-116.87%	-90.49%
ASP Isotopes Competitors	-21.17%	0.85%	-7.44%

Analyst Recommendations

This is a summary of current recommendations for ASP Isotopes and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	0	0	0	0	N/A
ASP Isotopes Competitors	31	330	310	6	2.43

As a group, “Miscellaneous chemical products” companies have a potential upside of 16.55%. Given ASP Isotopes’ peers higher probable upside, analysts plainly believe ASP Isotopes has less favorable growth aspects than its peers.

Insider and Institutional Ownership

1.5% of ASP Isotopes shares are owned by institutional investors. Comparatively, 72.6% of shares of all “Miscellaneous chemical products” companies are owned by institutional investors. 14.1% of shares of all “Miscellaneous chemical products” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

ASP Isotopes peers beat ASP Isotopes on 8 of the 9 factors compared.

About ASP Isotopes

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.